Clinical TrialsSearch results
Number of results: 1185
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Trial for Cerebellar Ataxia Rehabilitation
- Spinocerebellar degeneration
- Brain Research Institute, Niigata University
- 2007-09-12
Other
- Sequential chemotherapy with FEC(fluoraouracil, epirubicin and cyclophosphamide) and P+H(weekly Paclitaxel+Trastuzumab) as primary systemic therapy for operable breast cancer with HER2 positive disease-a phase 2 study
- Breast Cancer
- Breast Cancer PST Study Group
- 2005-10-16
Other
- Assessment of the efficacy of the use of zoledronic acid in the prevention of aromatase inhibitor-associated bone loss in postmenopausal women with hormone receptor-positive breast cancer who received letrozole as adjuvant therapy
- Postmenopausal Breast Cancer
- Cancer Institute Hospital
- 2008-03-29
Other
- Immunotherapy using WT1 peptide against recurrent glioblastoma multiforme: A phase I/II study.
- glioblastoma multiforme
- Cancer Vaccination Therapy Research Network, Department of Immunology, Kochi Medical School
- 2009-06-01
Recruiting
- Prognostic study of risk stratification among Japanese patients with chronic kidney disease and ischemic heart disease using gated myocardial perfusion SPECT
- Chronic kidney disease, Ischemic heart disease
- Cardiovascular research foundation
- 2009-04-30
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematologic diseases (C-SHOT 0402 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2005-08-29
Other
- Japan Morning Surge - Home Blood Pressure (J-HOP) study
- Subjects with any cardiovascular risk factors
- Center of Excellence (COE) Program / Division of Cardiovascular Medicine, Jichi Medical University
- 2007-11-15
Other
- Open Label Extension Protocol (Japan):Assess the Efficacy and Safety of Beremagene Geperpavec (B-VEC, previously KB103) for the Treatment of Japanese Patients with Dystrophic Epidermolysis Bullosa (DEB)
- Dystrophic Epidermolysis Bullosa
- Chien David
- 2023-07-21
Recruiting
- A single-center, open-label, uncontrolled study to evaluate the safety and tolerability of EVA101 with non-oxygenated perfluorodecalin (PFD) in healthy male volunteers
- Healthy Male Subjects
- Chihiro Yokota
- 2024-05-30